Clinical Policy Bulletin: Vagus Nerve Stimulation
ثبت نشده
چکیده
Aetna considers vagus nerve electrical stimulators medically necessary durable medical equipment (DME) for shortening the duration or reducing the severity of seizures in members with partial onset seizures who remain refractory to optimal anti-epileptic medications and/or surgical intervention, or who have debilitating side effects from anti-epileptic medications. (Note: Electronic analysis of an implanted neurostimulator pulse generator system for vagus nerve stimulation is considered medically necessary when criteria are met).
منابع مشابه
Protective effects of an interaction between vagus nerve and melatonin on gastric ischemia/reperfusion: the role of oxidative stress
Objectives:Vagal pathways in gastrointestinal tract are the most important pathways that regulate ischemia/reperfusion (I/R). Gastrointestinal tract is one of the important sources of melatonin production. The aim of this study was to investigate probable protective effect of the interaction between vagus nerve and melatonin after I/R. Materials and methods:This study was performed in male rat...
متن کاملVagus nerve stimulation in the treatment of nervous system disease: a review article
The vagus nerve (VN), the longest cranial nerve and an essential part of the parasympathetic system, connects the central nervous system to respiratory, cardiovascular, immune, gastrointestinal, and endocrine systems and is involved in the maintenance of homeostasis by controlling these systems. Vagus nerve stimulation (VNS) is related to any method that would stimulate the vagal nerve via elec...
متن کامل7.01.20 Vagus Nerve Stimulation
Policy [TOP] Vagus nerve stimulation may be considered medically necessary as a treatment of medically refractory seizures. Vagus nerve stimulation is considered investigational as a treatment of other conditions, including but not limited Non-implantable vagus nerve stimulation devices are considered investigational for all indications.
متن کاملClinical Policy Bulletin: Alzheimer's Disease: Experimental Treatments
Policy Aetna considers the following treatments for Alzheimer's disease (AD) experimental and investigational because their effectiveness for this indication has not been established (not an all inclusive list). Adoptive imunotherapy (see CPB 0641-Adoptive Immunotherapy and and Cellular Therapy) Applied behavior analysis Bapineuzumab Beta-amyloid degrading enzymes including cathepsin B, neprily...
متن کاملClinical Policy Title: Vagus nerve stimulation (VNS)
ABOUT THIS POLICY: AmeriHealth Caritas Louisiana has developed clinical policies to assist with making coverage determinations. AmeriHealth Caritas Louisiana’s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional so...
متن کامل